News

Columnists G Shellye Horowitz, caught up in an art project, forgot that she was living with hemophilia and needed treatment. Oops.
Pfizer recently announced positive results from the BASIS study, the global phase 3 trial evaluating Hympavzi in young adults ...
Among the 83 appointees in 2025 are Albert Friesen and Kathy Mulder, both from Winnipeg, as well as Steinbach's Miriam Toews.
NEW YORK, NY, USA I June 26, 2025 I Pfizer Inc. (NYSE: PFE)today announced positive topline results from the Phase 3 BASIS study (NCT03938792) evaluating ...
Just days after his oldest son was born, columnist Joe MacDonald received astonishing news: Baby Julian had severe hemophilia A.
Novo Nordisk A/S recently presented data regarding their antibody fragment Inno-8 for the potential treatment of hemophilia A. Inno-8 was characterized in vitro alone or in combination with hemostatic ...
Bispecific antibodies mimicking coagulation factor VIIIa (FVIIIa) have yielded successful results in the treatment of hemophilia A, but there remain some issues in regard to their production.
World Hemophilia Day: How To Recognise This Rare Bleeding Disorder Even though it is a rare condition, awareness about hemophilia is necessary to manage the condition. Read on to know about the ...
World Hemophilia Day is observed on April 17. It raises awareness about bleeding disorders. Hemophilia is a genetic condition causing prolonged bleeding. Early diagnosis and treatment are crucial.
World Hemophilia Day 2025 is a call to action for governments, healthcare providers, and advocates worldwide to close the gaps in care for women and girls with bleeding disorders.
World Hemophilia Day 2025 is a call to action for governments, healthcare providers, and advocates worldwide to close the gaps in care for women and girls with bleeding disorders.